Tenax Therapeutics, Inc.
TENX· Nasdaq
TENXTenax Therapeutics, Inc.
Filed Nov 16, 2020 · 10-Q · 47 days after period end · 0001654954-20-012485
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Net Income | -$2.22M | $2.22M | $1.54M | $1.23M |
| EPS Diluted | -$0.18 | -$0.33 | -$1.05 | -$0.87 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenax Therapeutics, Inc. · CIK 34956 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 16, 2020 · 47 d after period end
